Neurological Implications of the Genetic Mouse Models for Human Phenylketonuria and Hyperphenylalaninemia
Author:
Mcdonald J. David
Reference66 articles.
1. Allen, I. V., and Kirk, J., 1992, “Greenfield’s Neuropathology,” 5th ed. (J. H. Adams and L. W. Duchen, eds.), pp. 447–520, Oxford University Press, New York. 2. Armstrong, M. D., and Tyler, F. H., 1955, Studies on phenylketonuria. I. Restricted phenylalanine intake in phenylketonuria, J. Clin. Invest. 34:565–580. 3. Bickel, H., Gerrard, J., and Hickmans, E. M., 1954, The influence of phenylalanine intake on the chemistry and behavior of a phenylketonuria child, Acta Pediatr. Scand. 43:64–77. 4. Bode, V., McDonald, J. D., Guenet, J-L., and Simon, D., 1988, hph-1: A mouse mutant with hereditary hyperphenylalaninemia induced by ethylnitrosourea mutagenesis, Genetics 118:299–305. 5. Brand, M. P., Reales, S. J. R., and Clark, J. B., 1995, Tetrahydrobiopterin deficiency and brain nitric oxide synthase in the HPH-1 mouse, J. Inher. Metab. Dis. 18:33–39.
|
|